In a study that included 80 T2DM patients and 79 apparently healthy controls, the ferric reducing ability of plasma, γ-glutamyltransferase, and plasma glutathione reductase (GR) levels were significantly higher in patients with diabetes than those in nondiabetic people [26]. This evidence concerns the gene GSR and type 2 diabetes mellitus.